To fill this gap, we used a large dataset representative of commercially insured adults in the United States to conduct a retrospective cohort study characterizing patterns of non-insulin diabetes medication use among patients with type 2 diabetes as they transition to insulin therapy. Here, INS is linked to type 2 diabetes mellitus.